Gene · 1063
Papers2,501
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,501
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| STLBRF: an improved random forest algorithm based on standardized-threshold for feature screening of gene expression data. | Brief Funct Genomics | 2025 | 39736135 | PubTator, text mining | PubMed |
| Knockdown of CENPF induces cell cycle arrest and inhibits epithelial‑mesenchymal transition progression in glioma. | Oncol Lett | 2025 | 39611064 | PubTator, text mining | PubMed |
| LINCRNA01094 Promotes Renal Interstitial Fibrosis via the Mir-513b-5p/ MELK/Smad3 Axis. | Endocr Metab Immune Disord Drug Targets | 2025 | 39318012 | PubTator, text mining | PubMed |
| Identification of potential biomarkers for pancreatic ductal adenocarcinoma: a bioinformatics analysis. | Comput Methods Biomech Biomed Engin | 2025 | 38773913 | PubTator, text mining | PubMed |
| Identification of MAD2L1 and BUB1B as Potential Biomarkers Associated with Progression and Prognosis of Ovarian Cancer. | Biochem Genet | 2025 | 38683465 | PubTator, text mining | PubMed |
| NUF2 is associated with cancer stem cell characteristics and a potential drug target for prostate cancer. | Front Mol Biosci | 2024 | 39703688 | PubTator, text mining | PubMed |
| DeSUMOylating isopeptidase 1 participates in the faithful chromosome segregation and vincristine sensitivity. | FASEB J | 2024 | 39698932 | PubTator, text mining | PubMed |
| Integrated analysis of hub genes and intrinsically disordered regions in triple-negative breast cancer. | J Genet Eng Biotechnol | 2024 | 39674628 | PubTator, text mining | PubMed |
| Deciphering molecular landscape of breast cancer progression and insights from functional genomics and therapeutic explorations followed by in vitro validation. | Sci Rep | 2024 | 39567714 | PubTator, text mining | PubMed |
| Unveiling novel prognostic biomarkers and therapeutic targets for HBV-associated hepatocellular carcinoma through integrated bioinformatic analysis. | Medicine (Baltimore) | 2024 | 39470543 | PubTator, text mining | PubMed |
| A Bioinformatics-Based Approach to Discover Novel Biomarkers in Hepatocellular Carcinoma. | Iran J Public Health | 2024 | 39430152 | PubTator, text mining | PubMed |
| Integrated bioinformatic analysis reveals the gene signatures, epigenetic roles, and regulatory networks in endometriosis. | Eur J Obstet Gynecol Reprod Biol | 2024 | 39306912 | PubTator, text mining | PubMed |
| Identification of Hub Genes in Comorbidity of Psoriasis and Vitiligo Using Bioinformatics Analysis. | Clin Cosmet Investig Dermatol | 2024 | 39258216 | PubTator, text mining | PubMed |
| On discovery of novel hub genes for ER+ and TN breast cancer types through RNA seq data analyses and classification models. | Sci Rep | 2024 | 39242688 | PubTator, text mining | PubMed |
| Esophageal chemical burns as a risk factor for esophageal malignancies: in-silico analyses - experimental research. | Ann Med Surg (Lond) | 2024 | 39239040 | PubTator, text mining | PubMed |
| Intraglandular dissemination: a special pathological feature. | Front Oncol | 2024 | 39135992 | PubTator, text mining | PubMed |
| Deciphering the Molecular Complexity of Hepatocellular Carcinoma: Unveiling Novel Biomarkers and Therapeutic Targets Through Advanced Bioinformatics Analysis. | Cancer Rep (Hoboken) | 2024 | 39118438 | PubTator, text mining | PubMed |
| Doxorubicin downregulates cell cycle regulatory hub genes in breast cancer cells. | Med Oncol | 2024 | 39115587 | PubTator, text mining | PubMed |
| Reconstruction of single-cell lineage trajectories and identification of diversity in fates during the epithelial-to-mesenchymal transition. | Proc Natl Acad Sci U S A | 2024 | 39093947 | PubTator, text mining | PubMed |
| Machine learning and bioinformatics analysis of diagnostic biomarkers associated with the occurrence and development of lung adenocarcinoma. | PeerJ | 2024 | 39071134 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1063/papers?page=6